Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Your exhortation brings to mind a scene in the movie "Animal House" where John Belushi is similarly urging his fellows to action.
"Who is with me? C'mon!"
"Arghhh!"
...pretty much sums up the situation here.
:)
There is also a possibility of fund managers who haven't done well this year taking a calculated risk to try to score a quick boost for their portfolio by the end of the year. AVXL would be an attractive choice for that if they've done their homework.
When they do implement reforms, it seems like it always tends to hurt retail investors . I guess eliminating stop loss orders would prevent "running the stops", I won't miss them. But GTC? That comes in handy, especially if you trade low volume OTC. Wonder what the rationale is for that. Now will need to re-enter order every day.
Reading through a lot of the reports I think I saw something about one of the trials not meeting primary endpoint but that it passed secondary. Now I can't find it again. Can someone around the board here, perhaps, outline where things are at.
My impression is that the artery unclogging drug worked as far as indications 8n the blood serum but not clear from my reading so far, how well does it work on unclogging arteries?
Seems like Canadian stockholders could at least write to HC politely asking them to please publish an inspection schedule, even if it is just a rough estimate. It's not knowing when and HC'S unwarranted secrecy that is causing financial losses all around.
If that doesn't work, then... class action suit against HC?
Can you sue a government agency in Canada?
That is funny! :)
Well, no harm done, except for Tilray shooting themselves in the foot. lol
What did they do?
It was a surprise attack. That's why it was so successful (so far). Only now are people trying to put the pieces together.
I have a couple other bio-tech stocks with encouraging results for previously incurable conditions, also, like AVXL not overhyped and so forth, that don't fit that risk profile. Just the usual quantifiable risk associated with ongoing human study trials. These others so far haven't been targeted. One wouldn't expect them to be. The stock "gurus" writing hit pieces on AVXL coinciding with the nosedive might have been construed as warning but their criticisms didn't make any sense. They still don't.
Oh, good. I know the rules have changed a bit over the years, particularly since the last crash when a lot of major companies were brought low. Actually they are a bit more lenient. Seems like it used to be $5. Anyway thanks for the update.
I don't think we need to worry about that for AVXL, not there yet although this is proving to be an unusually aggressive attack, though this sort of thing has been going on for years.
Hopefully whoever is doing this is just in it for short term gains and not on some kind of larger mission. I guess that we will find out sooner or later.
I think at least truth if not justice will prevail this time, but it's hard to predict how much financial pain investors will need to suffer through in the meantime.
Maybe creative writing is extra. :)
I don't know for sure. I seem to recall that companies get a notice after 30 days and then have months, I think, what, 6 months maybe to go back into compliance. Then I think it can be appealed or extended even beyond that. Considering how long MHR hung on, I think major exchanges these days are reluctant to kick anybody out if there is any hope for them to recover.
Couldn't your finding be attached as a comment to the hit piece that cites him, on SA or wherever it was
re: who has the most to lose?
Is not AXON the competitor who stands to lose market share if their mediocre drug is displaced by a better one? Also if one looks to who is behind AXON and their connections, it is not hard to imagine the limits of business ethics being stretched in an attempt to stifle the competition before it can make it out of the gate.
Well done. Well said.
I am staying invested for those reasons as well.
If it was the same $100 million hedge forcing it down that bought it, they wouldn't have a problem. Actually, they'd only need to buy 51%... hypothetically speaking.
Checking the overnight: Looks like France is really ticked off (justifiably) and bombing the cr@p out of ISIS held oil supplies. This has caused crude oil to gap up a bit, which has in turn caused the major index futures to go green presumably bouyed by the S&P which has a lot of oil stock. Improved overall invester sentiment should increase the trickle of AVXL buyers, and may very well give us some bouyancy today.
Geez. Although 10 cups of coffee works for me, you might consider cutting back on your caffeine intake. :)
I think it more likely a gradual improvement over the coming weeks as the tide of mass deception slowly gets turned back. We could still get dunked in the abyss though I think that is getting less likely as more people find factual information beyond the chanting of the false pundits. That's a slow process and it's probably going to take a long while yet.
Scottrade let's you trade ADR's on-line for a flat commission, $7 per trade for stocks over a dollar. There is a small additional commission of 0.5% of the order total for stocks under a dollar. I think they also have "broker assisted" for direct trading in foreign stocks if they do not have an ADR for $35...
"skin in the game" as they say...
AXON sounds like it could be one of MEGATRON'S evil robot minions. Of course it would also have minions of its own :)
It's a preposterous soft bash. That would be $0.25 pre-split. Heck, the asset value of the office furniture is higher than that. :)
re: Does anyone here believe this drug could prevent or cure Alzheimer's?
There is reason to believe.
One thing that doesn't help is AVXL getting maligned on other message boards. I discovered this on YMB when I was checking discussion about one of my other biotech holdings. People being warned not to buy AVXL based on bogus prattle about placebo and practice effect, scam, yadda yadda. The stock board in question has nothing to do with Alzheimer's. How far does the blitzkrieg extend? There are a heck of a lot of biotech stock message boards out there. How many missionaries of mistruth have been deployed how far and wide ...
At least I haven't seen AVXL getting bashed on mining stock boards, (yet). :)
re: "i still feel the american volume (altho higher) was very anemic in twmjf."
As an ADR holder, the drop in the Canadian vs. Us dollar has been rough. It's dropped, like 10% this year with a corresponding drop in valuation of the ADR's. It looked like it was going to start to equalize a bit for a while there which you might have noticed an increase of buying. So long as the can/us spread keeps widening, investors will tend to wait ...
re:
http://seekingalpha.com/article/3444196-premarket-biotech-digest-axovant-analysis-anavex-gets-grant-pharmacyclis-imbruvica?auth_param=btpbb:1at3j0l:afa85ef47d3b60d78c9840325c93132b&uprof=45
I initiated coverage on AVXL almost a month ago. In the article, I had noted that AVXL appears to be the most interesting Alzheimer's disease ("AD") drug company with the lowest valuation. The potential of the company's lead product candidate, Anavex 2-73, was reconfirmed when it released initial data from a Phase 2a study last month. The data showed early evidence of improving condition in patients with AD.
In AD alone, AVXL has a fair value of $5 per share, after adjusting for risk. If you add the potential in Parkinson's, then the potential value of the stock is even higher. If AVXL's concept is proven in AD, it is very likely that it will be proven in Parkinson's as well. "
I wonder if a lot of people finding that elsewhere realize that since the article was written in April pre-split that the $5.00 he mentions is really $20.00 now.
re: "It is a rough game in a rough world."
Roll with it. :)
http://www.bing.com/videos/search?q=steve+winwood+roll+with+it&filters=ufn%3a%22steve+winwood+roll+with+it%22+sid%3a%22e91c0308-69b6-a0e3-7f71-f613434ac19c%22+catguid%3a%22a6c0380e-3858-4f4c-3391-1aeaffac7117_498707c2%22+segment%3a%22generic.carousel%22+secq%3a%22steve+winwood+arc+of+a+diver%22+psid%3a%22a6c0380e-3858-4f4c-3391-1aeaffac7117%22+supwlcar%3a%220%22+segtype%3a%22U29uZw%3d%3d%22&FORM=VRMRAL&crslsl=0
Seems to me a good model might be that LP's would be the only certified suppliers for medical marijuana but that anyone of age looking for the highest quality possible could buy it if they wanted to. The difference would be if they had a prescription they would not have to pay tax on it. LP's could still also offer non-therapeutic grades at presumably lower cost for recreational use.
I bought SIMH since they supposedly had an "in" with government procurement and intended to corner the ebola screening thermometer market. I ignored warnings about death spiral financing, the fact that management was raking in rich salaries in spite 8f the fact that the company was broke, and all other endeavors by them were failures. The reverse split came and it just kept plummeting. Was left with about $100 out of $2000.
So I've become a bit skeptical if not cynical, here.
However sometimes these things are still like a magnet to me I guess. Spur of the moment, I actually had a bid in for a $100 worth @ 0.075 but never got a fill. Spin the roulette wheel. If there is any chance they can turn this around...I don't know.
Slim and None. And Slim's about to leave town.
re: No short squeeze coming
Agreed. Not today, probably not ever on this stock. These are not "normal" trading conditions.
Looks to me like they covered already based on volume symetries if you look at the daily candle chart. I surmise that the first three days of the drop were mostly real shares they bought on the way up to amplify the frenzy of momentum buying flooding in. The sharp peak is where they shifted strategic gears to selling. Then probably created naked iou shares on the last day to keep running the stops and the walkdown going. Tuesday was covering for Wednesday's selling, notice the similar volumes. Thursday's doji signifys covering is complete. Now they are reloaded and can quash any rally that starts to form at their whim with tactical dump/cover.
Back of envelope calculation:
About 40m os... $5b market. Say we get $2b of that... generic pills are 10% profit. This is not generic, so, say, 50% = worst case (conservative) 1b/40m = $25 per share. Now, when? Say, 2 years. Draw a line from the low point (when we hit it, if we haven't already) to there. PPS should wander along that line when things normalize. At least, that is how I have adjusted my expectations. A fine return nonetheless. Just have to wait.
This would probably tell you.
http://realshortdata.com/ygr803yt8ui8707676a7j9sm3fyui807w88707676a7j9s/
You need a subscription but it's not very expensive. $5.00 for the first month then about $10.00 / mo. after.
I haven't got a subscription yet but am thinking about it. Fwiw, it seems better than another one I looked at.
People complaining to the SEC should probably include references or links to articles like these. They don't seem too adept at uncovering things on their own and only recently seem to have discovered computers, (e.g. twitter as a vehicle for perpetrating fraudulent activity).
Yeah, the packaging...
Question is, who's copying who?
The whole venom as a miracle substance thing is so interesting. Too bad it's probably not going to be investable.
. I think they probably have a quality / process control deficiency causing variable results based on the customer reviews. I don't think the substance is necessarily ineffective. I agree the current management is what appears to be totally ineffective.
Uh Oh Competition.
CobraZol
http://www.cobrazol.com/pain-relief/
It's not the same guys. Reading the faqa, They have evidently improved the formula by using 3 different snakes. These guys don't seem so screwed up.
Wonder what the co. / ticker is...
Me, a teacher? Thanks. No, just an old tech geek. Funny no one ever mentioned that before but it might be something I could do.
Good way to get free apples. :)
I just had an idea. After this becomes the new standard of care, there will probably be increased demand for ruthenium and osmium unlike palladium which is currently in free fall. They are found with PGM (platinum group metals) but currently I think are considered more of a trace impurity nuisance by precious metal miners. Also, they don't seem to report how much % of these elements they have in their ore. A research challenge would be to find a gold / pgm junior that isn't a total basket case that would be the purest play on these currently offbeat elements.
All the miners are pretty beat up right now and represent bargain prices depending on the future market for their metals. There is only one NA choice I can think of offhand but they don't seem to mention the elements in question prominently as production. Is anybody familiar with others, maybe in out of the way places, that may have actually significant amounts of ruthenium/osmium?
That makes no sense to me as a defense against a short (phantom shares) dumping attack.
Normally, yes, when someone buys at the ask, A normal market maker may sell you short shares but will cover as he goes, buying at the bid. And yes, as the top entry in his order book gets depleted, everything moves up a notch in a normal market maker situation, as he wants to keep the spread small and is content with the small arbitrage. And, a big surge of buying at the ask can overwhelm the MM and up it goes.
When we got the first drop I remember thinking, "guess they found some shares..." But when it kept power diving down, it's like, where are all these millions of shares coming from? Out of nowhere?
If a hedge fund is trying to drive the price down, they will be dropping shares on the bid like bombs, until there are no more buyers in that MM top order book entry. It depletes and drops to the next bid lower level, and meanwhile created shares are constantly replentishing the ask at lower prices. Remember, they are not interested in covering at this point. If ever. Maybe a month from now at pennies on the dollar. That is their goal. Nobody being on the bid makes the bid disappear and it drops to the next lower bid, and so on.
In this situation, if everybody sits on the bid, this slows the process, and you will get a better price. If you have to wait for a fill, then you have paused the walk-down process. At this point they may shut off the flood gates and the trickle of impatient buyers coming in will start the ask to jump up on low volume. If they can get people to break ranks and chase the ask up leaving the bid unprotected, then it's time to open the floodgates again. The spread has widened, meanwhile, the bid has been bombed lower and everything resumes at a lower share price.
I think what you need is a huge block on the bid like an inpenetrable barrior, then creep it up bit by bit. Wouldn't we like a nice constant slow steady increase? Somehow I don't think retail can pull it off but surelty even hedge funds have their limits. Actually, it would probably take another hedge fund, somehow on our side, to pull it off.
Aren't there any nice hedge funds out there that could help us? There are billionaire philanthropists who denote millions for reaearching cures for degenerating brain disease. Here they wouldn't even have to donate, and even make a little honest investment money while helping the cause.
Agreed. Pretty safe to say that it's probably not retail that has been taking this down. imho
As a retail investor you can stay short as long as you want but you have to pay periodic maintenance (interest) because it is, basically, a loan. Obviously, the interest payments add up, so, after a while, if the strategy isn't going anywhere, the incentive is there to buy back shares at some point that then get returned to your broker's inventory to cover the "empty space" back up that was left behind by the ones you borrowed, after which the loan (short position) is closed out.
Shorting is kind of neat in a way. Let's say I shorted 100 shares of AXON this morning @18.00. -Poof- I immediately saw $1800 deposited in my account like magic. Money for nothing. Well, not really. That counts against margin. So, just like buying long on margin, if you don't leave yourself enough slack, and the trade goes against you, you can run out of margin, after which you've got trouble, It's like exceeding your credit card limit. Here, it's called a margin call- when your broker calls you to tell you that you screwed up. Now your broker is probably friendly and helpful and all that but they only really trust you as far as they can throw you. You face loss of trading privileges if you don't make things right, right away. You don't necessary have to cover, but you will need to deposit more cash or sell other positions you might have. Or your broker will liquidate them for you.
Shorting is very dangerous unless you have extremely good research or some kind of lock on what's going to happen. After all, the most you can make on a short trade is 100% if the equity goes to zero. But your losses can theoretically be infinite because there is no limit on how high the price of a stock can go.
Of course, multi-million dollar hedge funds are a whole different level and there is some debate as to how much leverage and power they can wield though it is generally agreed to be somewhere in the god-like realm. :)
Yes, feckless at best, at worst, well, very bad.
It's a shame, even if only part of the products claims are true, they still would really have something here. Unfortunately, there appears to be no clue of how or little intent to run an actual going concern.
I think this the bottling facility they used based on the 10k note about getting sued for non-payment.
http://liquidpackagingcompany.com/our-products.html
It looks like industrial lubricants and chemicals are more their thing. Purity and consistent micro gram concentrations usually aren't a big concern with toilet cleaner, and how well can they flush out their tanks between batches of brake fluid and anti-freeze to run cobroxin. Couldn't say it would be my first choice for packaging medicine, homeopathic or otherwise, for human use.